Cargando…
Estimates of epidemiology, mortality and disease burden associated with progressive fibrosing interstitial lung disease in France (the PROGRESS study)
BACKGROUND: There is a paucity of data on the epidemiology, survival estimates and healthcare resource utilisation and associated costs of patients with progressive fibrosing interstitial lung disease (PF-ILD) in France. An algorithm for extracting claims data was developed to indirectly identify an...
Autores principales: | Nasser, Mouhamad, Larrieu, Sophie, Boussel, Loic, Si-Mohamed, Salim, Bazin, Fabienne, Marque, Sébastien, Massol, Jacques, Thivolet-Bejui, Françoise, Chalabreysse, Lara, Maucort-Boulch, Delphine, Hachulla, Eric, Jouneau, Stéphane, Le Lay, Katell, Cottin, Vincent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147348/ https://www.ncbi.nlm.nih.gov/pubmed/34030695 http://dx.doi.org/10.1186/s12931-021-01749-1 |
Ejemplares similares
-
Progressive fibrosing interstitial lung disease: a clinical cohort (the PROGRESS study)
por: Nasser, Mouhamad, et al.
Publicado: (2021) -
Epidemiology, Mortality and Healthcare Resource Utilization Associated With Systemic Sclerosis-Associated Interstitial Lung Disease in France
por: Cottin, Vincent, et al.
Publicado: (2021) -
Predictors of mortality in subjects with progressive fibrosing interstitial lung diseases
por: Brown, Kevin K., et al.
Publicado: (2022) -
The Burden of Progressive-Fibrosing Interstitial Lung Diseases
por: Cottin, Vincent, et al.
Publicado: (2022) -
Nintedanib in idiopathic and secondary pleuroparenchymal fibroelastosis
por: Nasser, Mouhamad, et al.
Publicado: (2021)